MoneyWorks4Me

Sandu Pharmaceutical - Quaterly Results

05 Jun 2024 Evaluate
The quarter ended March 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 155.98 millions.The Net Profit of the company vaulted to 116.42% to Rs. 5.93  millions from Rs. 2.74 millions in the previous quarter.Operating profit surged to 9.10 millions from the corresponding previous quarter of 5.28 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 155.98 152.65 2.18 672.81 653.49 2.96 672.81 653.49 2.96
Other Income 3.07 0.45 582.22 4.21 3.27 28.75 4.21 3.27 28.75
PBIDT 9.10 5.28 72.35 27.18 28.16 -3.48 27.18 28.16 -3.48
Interest 0.07 0.16 -56.25 0.63 0.80 -21.25 0.63 0.80 -21.25
PBDT 9.03 5.12 76.37 26.55 27.36 -2.96 26.55 27.36 -2.96
Depreciation 1.86 1.34 38.81 5.83 5.17 12.77 5.83 5.17 12.77
PBT 7.17 3.78 89.68 20.72 22.19 -6.62 20.72 22.19 -6.62
TAX 1.24 1.04 19.23 6.12 6.96 -12.07 6.12 6.96 -12.07
Deferred Tax -0.86 0.03 -2966.67 0.25 0.34 -26.47 0.25 0.34 -26.47
PAT 5.93 2.74 116.42 14.60 15.23 -4.14 14.60 15.23 -4.14
Equity 96.61 96.61 0.00 96.61 96.61 0.00 96.61 96.61 0.00
PBIDTM(%) 5.83 3.46 68.67 4.04 4.31 -6.25 4.04 4.31 -6.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..